JINKO is NOVA’s unified in silico clinical trial simulation platform.

Jinko

With Artificial Intelligence and virtual populations at the heart of NOVA’s innovative approach, the platform takes its name from the fortunate homonymic collision of the Japanese words for ‘artificial’ (人工, jinkō) and ‘population’ (人口, jinkō).

Learn more
Jinko

We help biotech and pharma companies generate new insights, de-risk and accelerate research programs and reduce cost of development.

We build mathematical models of disease and treatment based on knowledge extracted from literature and real-world patient data.

  • Discovery

    Streamline target identification & secure early proof of concept

    Learn more
  • Clinical development

    Optimize trial design and capture best responders

    Learn more
  • Market access

    Demonstrate value to payers

    Learn more

content Do you want to learn more about in silico clinical trials ?

Take a look at our white book

Go to download page
In Silico white book

We are NOVA

We pride ourselves on attracting the most talented individuals in our industry. Our interdisciplinary team combines expertise in biology, medicine, clinical pharmacology, applied mathematics, data science, artificial intelligence and software development.

We are a trusted partner

  • Enyo
  • Takeda
  • Janssen
  • Innate
  • omPharma
  • Theratech
  • op2
  • Erytech
  • Elsalys
  • Shire

Check out our latest updates

  • Conference

    World Conference on Lung Cancer 2021

    NOVA is participating in the IASLC - WCLC World Conference on Lung Cancer which is being held from today until September 14th. Adèle L'Hostis will present two posters about NSCLC with our partner Janssen: "Multiscale […]

    Read more
  • Hype cycle

    Novadiscovery (NOVA) is named as one of the "Trial Simulation" vendors in Gartner’s Hype Cycle for Life Science Research and Development, 2021

    According to Gartner, "Trials continue to get more expensive to run, and advanced technology, predictive analytics and simulation approaches can reduce enormous amounts of waste by ensuring the right trial is run. Synthetic arms can […]

    Read more
  • Article

    News on Artificial Intelligence in drug development

    Novadiscovery mentioned in the Emersion Insights report by Dr Ulrik Kristensen discussing the red-hot market for AI Drug Development. According to the research, startups including NOVA have already raised $2.1B in the first half of […]

    Read more

Julie

Is here to answer your questions or requests.

Do you have any questions for me?

If you want to join the team, please visit our careers section to see all vacancies available

Select a team please
First name is required
Last name is required
Job title is required
Company is required
Email is not valid
Message is required